Efficient gene transfer in CLL by mRNA electroporation

Leukemia

Volumn 22, Issue 2, 2008, Pages 323-329

  Van Bockstaele, F ^a   Pede, V ^a   Naessens, E ^a   Van Coppernolle, S ^a   Van Tendeloo, V ^b   Verhasselt, B ^a   Philippe J ^a  

^a GHENT UNIVERSITY   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ENHANCED GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; LENTIVIRUS VECTOR; MESSENGER RNA; PLASMID DNA; PROTEIN KINASE ZAP 70; RETROVIRUS VECTOR;

ARTICLE; CELL SURVIVAL; CELL VIABILITY; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; ELECTROPORATION; GENE OVEREXPRESSION; GENE TRANSFER; HUMAN; HUMAN CELL; IN VITRO STUDY; INTERMETHOD COMPARISON; LEUKEMIA CELL; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; SURVIVAL RATE; TRANSGENE; VIRAL GENE DELIVERY SYSTEM;

EID: 39149136507     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2405007     Document Type: Article

References (42)

1. Molica S, Alberti A. Prognostic value of the lymphocyte doubling time in chronic lymphocytic leukemia. Cancer 1987; 60: 2712-2716.
2. Montserrat E, Sanchez-Bisono J, Vinolas N, Rozman C. Lymphocyte doubling time in chronic lymphocytic leukaemia: Analysis of its prognostic significance. Br J Haematol 1986; 62: 567-575.
3. Dohner H, Stilgenbauer S, Benner A, Leupolt E, Krober A, Bullinger I. et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000; 343: 1910-1916.
4. Stilgenbauer S, Bullinger L, Lichter P, Dohner H. Genetics of chronic lymphocytic leukemia: Genomic aberrations and V(H) gene mutation status in pathogenesis and clinical course. Leukemia 2002; 16: 993-1007.
5. Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, Allen SL et al. Ig V gene mutation staus and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999; 94: 1840-1847.
6. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999; 94: 1848-1854.
7. Crespo M, Bosch F, Villamor N, Bellosillo B, Colomer D, Rozman M et al. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med 2003; 348: 1764-1775.
8. Wiestner A, Rosenwald A, Barry TS, Wright G, Davis RE, Henrickson SE et al. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood 2003; 101: 4944-4951.
9. Caligaris-Cappio F, Hamblin TJ. B-cell chronic lymphocytic leukemia: A bird of a different feather. J Clin Oncol 1999; 17: 399-408.
10. Cantwell MJ, Sharma S, Friedmann T, Kipps TJ. Adenovirus vector infection of chronic lymphocytic leukemia B cells. Blood 1996; 88: 4676-4683.
11. Huang MR, Olsson M, Kallin A, Pettersson U, Totterman TH. Efficient adenovirus-mediated gene transduction of normal and leukemic hematopoietic cells. Gene Ther 1997; 4: 1093-1099.
12. Kato K, Cantwell MJ, Sharma S, Kipps TJ. Gene transfer of CD40-ligand induces autologous immune recognition of chronic lymphocytic leukemia B cells. J Clin Invest 1998; 101: 1133-1141.
13. Wierda WG, Cantwell MJ, Woods SJ, Rassenti LZ, Prussak CE, Kipps TJ. CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia. Blood 2000; 96: 2917-2924.
14. Kofler DM, Buning H, Mayr C, Bund D, Baumert J, Hallek M et al. Engagement of the B-cell antigen recepwr (BCR) allows efficient transduction of ZAP-70-positive primary B-CLL cells by recombinant adeno-associated virus (rAAV) vectors. Gene Ther 2004; 11: 1416-1424.
15. Theiss HD, Kofler DM, Buning H, Aldenhoff AL, Kaess B, Decker T et al Enhancement of gene transfer with recombinant adeno-associated virus (rAAV) vectors into primary B-cell chronic lymphocytic leukemia cells by CpG-oligodeoxynucleotides. Exp Hematol 2003; 31: 1223-1229.
16. Wendtner CM, Kofler DM, Theiss HD, Kurzeder C, Buhmann R, Schweighofer C et al. Efficient gene transfer of CD40 ligand into primary B-CLL cells using recombinant adeno-associated virus (rAAV) vectors. Blood 2002; 100: 1655-1661.
17. Gresch O, Engel FB, Nesic D, Tran TT, England HM, Hickman ES et al New non-viral method for gene transfer into primary cells. Methods 2004; 33: 151-163.
18. Munkonge FM, Dean DA, Hillery E, Griesenbach U, Alton EW. Emerging significance of plasmid DNA nuclear import in gene therapy. Adv Drug Deliv Rev 2003; 55: 749-760.
19. Shimokawa T, Okumura K, Ra C. DNA induces apoptosis in electroporated human promonocytic cell line U937. Biochem Biophys Res Commun 2000; 270: 94-99.
20. Gordillo GM, Xia D, Mullins AN, Bergese SD, Orosz CG. Gene therapy in transplantation: Pathological consequences of unavoidable plasmid contamination with lipopglysaccharide. Transpl Immunol 1999; 7 83-94.
21. Bonehill A, Heirman C, Tuyaerts S, Michiels A, Zhang Y, van der Bruggen P et al. Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide. Cancer Res 2003; 63: 5587-5594.
22. Dullaers M, Breckpot K, Van Meirvenne S, Bonehill A, Tuyaerts S, Michiels A et al. Side-by-side comparison of lentivirally transduced and mRNA-electroporated dendritic cells: Implications for cancer immunotherapy protocols. Mol Ther 2004; 10: 768-779.
23. Michiels A, Tuyaerts S, Bonehill A, Corthals J, Breckpot K, Heirman C et al. Electroporation of immature and mature dendritic cells: implications for dendritic cell-based vaccines. Gene Ther 2005; 12: 772-782.
24. Van Tendeloo VF, Ponsaerts P, Lardon F, Nijs G, Lenjou M, Van Broeckhoven C et al. Highly pfficient gene delivery by mRNA electroporation in human hematopoietic cells: Superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells. Blood 2001; 98: 49-56.
25. Smits E, Ponsaerts P, Lenjou M, Nijs G, Van Bockstaele DR, Berneman ZN et al. RNA-based gene transfer for adult stem cells and T cells. Leukemia 2004; 18: 1898-1902.
26. Coughlin CM, Vance BA, Grupp SA, Vonderheide RH. RNA-transfected CD40-activated B cells induce functional T-cell responses against viral and tumor antigen targets: Implications for pediatric immunotherapy. Blood 2004; 103: 2046-2054.
27. Van den Bosch GA, Ponsaerts P, Nijs G, Lenjou M, Vanham G, Van Bockstaele DR et al. Ex vivo induction of viral antigen-specific CD8 T cell responses using mRNA-electroporated CD40-activated B cells. Clin Exp Immunol 2005; 139: 458-467.
28. Stove V, Van de Walle I, Naessens E, Coene E, Stove C, Plum J et al Human immunodeficiency virus Nef induces rapid internalization of the T-cell coreceptor CD8alphabeta. J Virol 2005; 79: 11422-11433.
29. Taghon T, Stolz F, De Smedt M, Cnockaert M, Verhasselt B, Plum J et al. HOX-A10 regulates hematopoietic lineage commitment: Evidence for a monocyte-specific transcription factor. Blood 2002; 99: 1197-1204.
30. Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002; 296 550-553.
31. Ponsaerts P, Van Tendeloo VF, Cools N, Van Driessche A, Lardon F, Nijs G et al. mRNA-electroporated mature dendritic cells retain transgene expression, phenotypical properties and stimulatory capacity after cryopreservation. Leukemia 2002; 16: 1324-1330.
32. Van Bockstaele F, Janssens A, Piette A, Callewaert F, Pede V, Offner F et al. Kolmogorov-Smirnov statistical test for analysis of ZAP-70 expression in B-CLL, compared with quantitative PCR and lgV(H) mutation status. Cytometry B Clin Cytom 2006; 70: 302-308.
33. Castro JE, Prada CE, Loria O, Kamal A, Chen L, Burrows FJ et al. ZAP-70 is a novel conditional heat shock protein 90 (Hsp90) client: inhibition of Hsp90 leads to ZAP-70 degradation, apoptosis, and impaired signaling in chronic lymphocytic leukemia. Blood 2005; 106: 2506-2512.
34. Chen L, Apgar J, Huynh L, Dicker F, Giago-McGahan T, Rassenti L et al ZAP-70 directly enhances IgM signaling in chronic lymphocytic leukemia. Blood 2005; 105: 2036-2041.
35. Dicker F, Kater AP, Prada CE, Fukuda T, Castro JE, Sun G et al. CD154 induces p73 to overcome the resistance to apoptosis of chronic lymphocytic leukemia cells lacking functional p53. Blood 2006; 108: 3450-3457.
36. Endo T, Nishio M, Enzier T, Cottam HB, Fukuda T, James DF et al. BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-kappaB pathway. Blood 2007; 109: 703-710.
37. Gobessi S, Laurenti L, Longo PG, Sica S, Leone G, Efremov DG. ZAP-70 enhances B-cell-receptor signaling despite absent or inefficient tyrosine kinase activation in chronic lymphocytic leukemia and lymphoma B cells. Blood 2007; 109: 2032-2039.
38. Longo PG, Laurenti L, Gobessi S, Petlickovski A, Pelosi M, Chiusolo P et al. The Akt signaling pathway determines the different proliferative capacity of chronic lymphocytic leukemia B-cells from patients with progressive and stable disease. Leukemia 2007; 21 110-120.
39. Tiwari S, Dong H, Kim EJ, Weintraub L, Epstein PM, Lerner A. Type 4 cAMP phosphodiesterase (PDE4) inhibitors augment glucocorticoid-mediated apoptosis in B cell chronic lymphocytic leukemia (B-CLL) in the absence of exogenous adenylyl cyclase stimulation. Biochem Pharmacol 2005; 69: 473-483.
40. Li LH, Biagi E, Allen C, Shivakumar R, Weiss JM, Feller S et al. Rapid and efficient nonviral gene delivery of CD154 to primary chronic lymphocytic leukemia cells. Cancer Gene Ther 2006; 13: 215-224.
41. van den Hoff MJ, Moorman AF, Lamers WH. Electroporation in 'intracellular' buffer increases cell survival. Nucleic Acids Res 1992; 20: 2902.
42. Sloan-Lancaster J, Zhang W, Presley J, Williams, BL, Abraham RT, Lippincott-Schwartz J et al. Regulation of ZAP-70 intracellular localization: Visualization with the green fluorescent protein. J Exp Med 1997; 186: 1713-1724.